Literature DB >> 11059953

Exhaled nitric oxide partitioned into alveolar, lower airways and nasal contributions.

M Högman1, N Drca, C Ehrstedt, P Meriläinen.   

Abstract

During the last year exhaled nitric oxide (NO) has been proposed as a marker of airway inflammation. More knowledge of the production and transfer of this molecule are needed in order for NO analysis to become a clinical tool. This was the aim of the study. Exhaled NO values from multiple flow rates were used to model alveolar NO, transfer rate and tissue concentration of NO in the airways. Three flows rates, 0.005, 0.1 and 0.51 sec(-1) were found to be optimal. The NO transfer rate of the airways was 9 +/- 2 ml sec(-1), the tissue source was 75 +/- 28 ppb and the alveolar fraction of NO was 2 +/- 1 ppb in 10 healthy subjects (mean +/- CI95%). In conclusion, we have shown that it is possible to get more information about the distribution of NO in the lungs and the airways than only a single value from one expiratory flow rate can give. Further studies will reveal if this airway modelling can be useful in disease of the respiratory system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11059953     DOI: 10.1053/rmed.2000.0872

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  17 in total

1.  Optimal flow rate sampling designs for studies with extended exhaled nitric oxide analysis.

Authors:  Noa Molshatski; Sandrah P Eckel
Journal:  J Breath Res       Date:  2017-02-22       Impact factor: 3.262

2.  Extended nitric oxide measurements in exhaled air of cystic fibrosis and healthy adults.

Authors:  Markus Hofer; Luzia Mueller; Thomas Rechsteiner; Christian Benden; Annette Boehler
Journal:  Lung       Date:  2009-08-08       Impact factor: 2.584

3.  Fractional exhaled nitric oxide exchange parameters among 9-year-old inner-city children.

Authors:  Maria José Rosa; Adnan Divjan; Lori Hoepner; Beverley J Sheares; Diurka Diaz; Kevin Gauvey-Kern; Frederica P Perera; Rachel L Miller; Matthew S Perzanowski
Journal:  Pediatr Pulmonol       Date:  2010-09-16

Review 4.  Exhaled nitric oxide in the diagnosis and management of asthma: clinical implications.

Authors:  G W Rodway; J Choi; L A Hoffman; J M Sethi
Journal:  Chron Respir Dis       Date:  2009       Impact factor: 2.444

5.  Estimation of parameters in the two-compartment model for exhaled nitric oxide.

Authors:  Sandrah P Eckel; William S Linn; Kiros Berhane; Edward B Rappaport; Muhammad T Salam; Yue Zhang; Frank D Gilliland
Journal:  PLoS One       Date:  2014-01-17       Impact factor: 3.240

Review 6.  Partitioned exhaled nitric oxide to non-invasively assess asthma.

Authors:  James L Puckett; Steven C George
Journal:  Respir Physiol Neurobiol       Date:  2008-07-31       Impact factor: 1.931

7.  Physiology and pathophysiology of respiratory mucosa of the nose and the paranasal sinuses.

Authors:  Achim G Beule
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2011-04-27

8.  IgE sensitisation in relation to flow-independent nitric oxide exchange parameters.

Authors:  Andrei Malinovschi; Christer Janson; Thomas Holmkvist; Dan Norbäck; Pekka Meriläinen; Marieann Högman
Journal:  Respir Res       Date:  2006-06-20

9.  Risk factors for acute asthma in tropical America: a case-control study in the City of Esmeraldas, Ecuador.

Authors:  Cristina Ardura-Garcia; Maritza Vaca; Gisela Oviedo; Carlos Sandoval; Lisa Workman; Alexander J Schuyler; Matthew S Perzanowski; Thomas A E Platts-Mills; Philip J Cooper
Journal:  Pediatr Allergy Immunol       Date:  2015-08       Impact factor: 6.377

10.  Alveolar nitric oxide and its role in pediatric asthma control assessment.

Authors:  Olaia Sardón; Paula Corcuera; Ane Aldasoro; Javier Korta; Javier Mintegui; José I Emparanza; Eduardo G Pérez-Yarza
Journal:  BMC Pulm Med       Date:  2014-08-04       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.